Oncimmune SeroTag is a proprietary biomarker discovery platform developed by Oncimmune, a leader in immunodiagnostics. This platform utilizes a high-throughput method to profile autoantibodies, aiding in the early detection and characterization of diseases such as cancer. Through its comprehensive analysis, SeroTag accelerates the identification of novel biomarkers, facilitating more accurate disease diagnosis and prognosis. The technology leverages the body's immune response for insights that can enhance personalized medicine approaches.